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Summary.-In a study of the vitamin C status of 50 patients with malignant disease,
46 had leucocyte levels less than the lower limit of the normal range (18-50,ug/108
W.B.C.) and of these 30 had very low levels (< 12-5 jug/108 W.B.C.). Physical signs
compatible with subclinical scurvy were frequently recorded and there was a signi-
ficant decrease in capillary fragility in those with the lowest levels. Most patients
had an inadequate dietary intake of ascorbic acid-containing foods and this was felt
to be the major factor in producing the vitamin depletion.
ALTHOUGH frank clinical scurvy is
relatively uncommon in the United King-
dom (Thomson, 1954), it has been recog-
nized that certain population groups may
have clinical or biochemical evidence of
low vitamin C stores. The groups which
have so far been identified as having
subnormal vitamin C levels include the
elderly (Andrews and Brook, 1966;
Dymock, 1970), those with peptic ulcera-
tion or previous gastric surgery (Cohen
and Duncan, 1967) and patients with
rheumatoid arthritis (Rinehart, Greenberg
and Baker, 1936; Sahud and Cohen, 1971).
As these population groups are likely to be
those who subsequently develop frank
clinical scurvy, their identification is
important. In this report we describe our
findings in an additional group ofpatients
whom we considered to be at risk, namely
patients with malignant disease.
PATIENTS AND METHODS
Fifty patientswith malignant disease were
studied, the sites of the primary neoplasm
being listed in Table I. The leucocyte
ascorbic acid level was measured in a sample
of peripheral blood by the method of Denson
and Bowers (1961). Each sample was
estimated in duplicate and the average ofthe
2 values taken as the result and expressed as
,g/108 W.B.C. The normal range in our
laboratory is 18-50,tg/108 W.B.C. In
patients with alterations in the total white or
platelet counts we applied the conversion
factor recommended by Gibson, Moore and
Goldberg (1966).
Two controlpopulations were also studied.
Firstly, a group of 25 healthy young adults
who were either medical students or members
of the unit staff and second, an age related
hospital population (50 patients) with a
variety of clinical conditions thought not to
be associated with ascorbic acid deficiency.
In addition, each patient was examined
for clinical signs which have been attributed
to vitamin C deficiency, including sublingual
petechiae, abnormal forearm or abdominal
TABLE I.- Location of the Primary Malig-
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hairs, hyperkeratosis of the skin and cuta-
neous ecchymoses.
In each patient the capillary fragility was
assessed using a Hess test and in some by the
Angiosterrometer of Parrot (Krasner and
Dymock, 1970). One of us (N.K.) also
obtained from each patient a retrospective
dietary history assessing the intake ofcalories,
fresh fruit and vegetables.
RESULTS
Leucocyte ascorbic acid levels
The analysis of the leucocyte ascorbic
acid levels in the 3 groups studied is given
in Table II. The patients with malignant
disease had the lowest levels, with a mean
value of 1151 (range 1.6-46.0) jg/108
W.B.C. Forty-six of these patients had
levels less than the normal range recorded
in our laboratory and 30 ofthem had levels
less than 12 5 ,g/108 W.B.C. (the mean of
the young adult population less 2 standard
deviations). The results in the patients
with malignancy differ significantly from
both those in the healthy young adults
(P < 0.001) and the age-related controls
(P < 0.05).
It was not possible to establish any
correlation between the site of the pri-
mary neoplasm and the leucocyte ascorbic
acid levels. In particular, the mean
levels in the patients with an alimentary
tract primary (12.9 lg/lO8 W.B.C.) did
not differ significantly from the mean of
thegroupasawhole (1 I 51 ,ug/108 W.B.C.).
Neither was there any difference in relation
to the age of the patients, the mean level
in those under the age of 65 being identical
(11-3/ag/108 W.B.C.) to that in the
patients who were 65 years of age or over.
Physical signs
Although none of the patients had
cutaneous ecchymoses, a majority (34
patients) had at least one of the physical
signs present. However, although the
abnormal physical signs (Table III) were
more common in the group of patients
with low vitamin C levels, the differences
were not significant.
Capillaryfragility
There was some correlation between
the results of both the Hess test and the
TABLE II.-Leucocyte Ascorbic Acid Levels in the 50 Patients with Malignant
Disease, in the Healthy Young Adults and in Age Related Control Subjects
Leucocyte ascorbic acid (,ug/108 W.B.C.)
I A I
Group
Patients with malignant disease
Age related controls
Healthy young adults
Number
studied
50
50
25
Mean and standard
error
11-51±0- 99
16 56+1 38
29-5±1-71
Range
1-6-461
3-1-62fP < 0-05 P < 0 001
19- 53 J
TABLE III. Comparison of Leucocyte Ascorbic Acid Levels with Physical Signs
which have been Associated with Scurvy and with Tests of Capillary Fragility
Physical sign or test of capillary fragility
rAbnormal or increased sublingual petechiae
Physical J Abnormal forearm or abdominal hairs
signs Follicular hyperkeratosis
LCutaneous ecchymoses
rHess test Positive
Tests of J Negative
capillary Angiosterrometer < 30 mm Hg (abnormal)
fragility treading 30 + mm Hg (normal)
Not tested
Leucocyte ascorbic
acid less than
12
- 5 ,g/108 W.B.C.
(30 patients)
12
12
11
0
10
20
6
13
11
Leucocyte ascorbic
acid
12* 5 ug/108W.B.C.
or greater
(20 patients)
5
7
6
0
3
17
1
14
5
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TABLE IV.-CoMparison of Leucocyte Ascorbic Acid Levels and an Assessment
of Dietary Content
Dietary details
Calorie intake good
Frequent fresh fruit and vegetables
Calorie intake reduced
Frequent fresh fruit and vegetables
Calorie intake good
Infrequent intake of fresh fruit and vegetables
Calorie intake reduced
Infrequent intake of fresh fruit and vegetables
Total in grades 2 or 3
Leucocyte ascorbic
acid less than
12- 5 ,zg/108 W.B.C.
(30 patients)
8
2
4
16
20
Leucocyte ascorbic
acid
12 - 5 jg/108 W.B.C.
or greater
(20 patients)
10
4
3
3
6
Angiosterrometer readings and the leuco-
cyte vitamin C level (Table III), both
having most abnormal results in the
patients with low levels but these did not
reach statistical significance.
Dietary assessment
In assessing the diet of these patients,
we used 4 arbitrary grades (Table IV).
There was a significant correlation at the
5% level between a reduced intake of
fresh fruit and vegetables and the vitamin
C levels. Twenty ofthe 30 patients with
a leucocyte vitamin C of < 12-5 ,tg/108
W.B.C. had a low fruit and vegetable
intake, compared with 6 of 20 in the
groups with higher vitamin C levels.
The ascorbic acid intake, as judged by
the dietary grading, did not differ signi-
ficantly in relation to the site of the
primary neoplasm although more patients
with a gastric neoplasm had a poor
dietary intake. Nevertheless, the mean
ascorbic acid level in these patients was
similar to those of other patient groups
and the group as a whole.
DISCUSSION
It iswidely accepted that the measure-
ment of leucocyte ascorbic acid levels
provides the best index of tissue levels
(Bartley, Krebs and O'Brien, 1953;
Crandon, Lund and Dill, 1940) although
Loh and Wilson (1971) suggest that the
leucocyte content indicates the amount
available for storage whilst plasma levels
give an indication of metabolic turnover.
From the results in the present study, it
would appear that the majority ofpatients
with malignant disease have minimal
tissue stores ofascorbic acid. Theultimate
test ofdepletion is the effect ofadminister-
ing the appropriate vitamin and subse-
quently demonstrating a rise in tissue
levels. Although not performed as part
of the present study, we have shown
previously a sustained rise in leucocyte
vitamin C levels in a patient with a carci-
noma of colon (unpublished data).
In many ways the results reported here
parallel those found in elderly patients
(Andrews and Brook, 1966), but a number
of our patients were in the younger age
groups. The role of dietary deficiency as
the explanation of these low levels is
attractive in view of the known anorexia
which occurs in association with neoplastic
disease. A similar deficient nutritional
intake is known to occur in elderly
patients (Exton-Smith et al., 1965). How-
ever, some patients had apparently excel-
lent food intake and ascorbic acid utiliza-
tion might be increased, as occurs in
infection (Harde, Rothstein and Ratish,
1935) and hyperthyroidism (Lewis, 1938).
A further explanation might be the
malabsorption of vitamin C from the
intestine, since patients with malignancy
are known to have intestinal malabsorp-
tion (Dymock et al., 1967). This may be
the less likely explanation in view of the
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minimal evidence of malabsorption of
vitamin C in patients with steatorrhoea
(Stewart and Booth, 1964).
Regardless of the aetiology of the
vitamin C depletion, we feel that patients
with malignancy should receive vitamin
supplements. Studies in other clinical
groups with low vitamin levels had
indicated clinical benefit in patients who
have received supplements (Brocklehurst
et al., 1968) and one study (Dymock and
Brocklehurst, 1973) reported an increased
mortality in the group of patients not
given therapeutic vitamin supplements.
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